Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Evaluate a treatment result of every two months versus as needed (PRN) after 3 initial
monthly intravitreal aflibercept for the Japanese age related macular degeneration.